Saturday, July 4, 2009 22:13 MDT
Idaho Business Review
subscribeSUBSCRIBE

subscribeWANT THREE FREE ISSUES?
Daily EmailDaily e-mail updates
Real Estate EmailReal Estate e-mail updates
ADVERTISING? | CLASSIFIEDS | GOT A TIP? | TOP LIST | EVENTS | HOME RSS 2.0 CONTACT US at 208.336.3768
SEARCH ARCHIVES
See stories on: Idaho Companies Idaho Industries Idaho People

idaho business news

New pharmaceutical plant coming to Post Falls

POSTED: 12:49 MDT Wednesday, June 20, 2007

by Eddie Kovsky

Article Tools
Printer friendly edition Printer-friendly
E-mail this to a friend E-mail this
RSS Feed RSS feed
Digg this story Digg It!
Add to Del.icio.us Del.icio.us
Add to Facebook
Add to Twitter

Tags -  ALK-Abelló Group, Biopol Laboratory, City of Post Falls

Biopol Laboratory – a part of the ALK-Abelló Group – is building a new manufacturing and research and development facility in Post Falls. The new facility will occupy 12.5 acres of land in Riverbend Commerce Park in Post Falls, the company said in a statement. The site will be the future home and main office for Biopol Laboratory – ALK-Abelló's largest production site of raw material for its allergy immunotherapy products.

The first phase of the construction will be approximately 68,000 sq. ft. with an initial investment of around $30 million. The facility should provide approximately 50 jobs when completed in 2009.

Biopol Laboratory currently operates out of five facilities in and around Spokane, Wash. and controls a 600-acre farm in Plummer, Idaho, just south of Kootenai County, where it grows a variety of grasses and other plants to produce pollens used as raw materials for allergy immunotherapy products.

Leave a comment
Leave this field empty

Name:

Email:


You have characters left.

Commenters, let's maintain a civil discussion here. Please observe the following guidelines:

  1. Do not use profanity or euphemisms for profanity.
  2. Do not personally attack or bait other commenters.
  3. Express your own views; don't just argue for argument's sake.
  4. Sarcasm doesn't work on the Web. Either avoid it or clearly label it so you aren't misinterpreted.
  5. Don't make the same point repetitively.
  6. No spam. Link to a commercial site only if it's relevant to the discussion.
  7. Putting your name on your comments increases their value and credibility. However, if you must conceal your identity, please choose one pseudonym and stick to it. No "sock puppets."